Medical management of dilated cardiomyopathy in livingstone fruit bats (Pteropus livingstonii)
Drane, Aimee L.
Wedi’i wahardd nes
MetadataDangos cofnod eitem llawn
Eleven cases of dilated cardiomyopathy have been diagnosed and treated in captive Livingstone fruit bats ( Pteropus livingstonii) in the United Kingdom over the past 7 yr. All but one case received treatment with a diuretic plus an angiotensin-converting enzyme inhibitor (ACEI), and, or pimobendan. One case is still under treatment with pimobendan alone, following diagnosis before onset of clinical signs. Diuretic treatment consisted of furosemide at a dose rate of 0.5-5 mg/kg, one to three times daily, and, or spironolactone at a dose rate of 1-4 mg/kg, once or twice daily. When used, the ACEI imidapril was given at a dose rate of 0.24-0.38 mg/kg q 24 hr, and pimobendan at a dose rate of 0.2-0.5 mg/kg bid. This report is intended to provide anyone seeking to medically manage heart failure in Pteropus species, particularly P. livingstonii, with a review of drugs and doses that have been used.
Journal of Zoo and Wildlife Medicine;
Killick, R., Barbon, A.R., Barrows, M., Routh, A., Saunders, R., Day, C., Naylor, A., Hayward, N., Sewell, D., Borgeat, K., Drane, A.L., Wilkie, L. (2017) 'Medical management of dilated cardiomyopathy in livingstone fruit bats (Pteropus livingstonii)', Journal of Zoo and Wildlife Medicine, 48(4), pp.1077-1080
Dynodwr Gwrthrych Digidol (DOI)https://doi.org/10.1638/2016-0211.1
This article was published in Journal of Zoo and Wildlife Medicine on December 01 2017 (online), available at https://doi.org/10.1638/2016-0211.1. Closed deposit. An Open Access version of the article is not available in this repository.
- Sport Research Groups